Related Experiment Videos
Second signal for T lymphocyte activation: multiple targets for pharmacological modulation
N Bonnefoy-Berard1, V Besnard, P Morel
1Laboratory of Immunology, INSERM U80 CNRS URA 1177 UCBL, Hôpital E. Herriot, Lyon, France.
Summary
This study introduces a new in vitro model to assess immunomodulators that enhance T cell activation. The model evaluates compounds affecting the second signal, crucial for T cell proliferation and immune responses.
Area of Science:
- Immunology
- Cellular Biology
- Drug Discovery
Background:
- T cell activation necessitates two signals: antigen recognition via the T cell receptor and co-stimulatory signals from adhesion molecules or cytokines.
- Immunomodulators can influence T cell responses by affecting these signals or later stages like cytokine production and receptor expression.
Purpose of the Study:
- To develop and validate an in vitro model for evaluating immunomodulators targeting the second signal of T cell activation.
- To assess the capacity of compounds to enhance adhesion molecule expression and monocyte cytokine synthesis, impacting T cell proliferation.
Main Methods:
- Devised an accessory cell depletion and reconstitution model for in vitro T cell activation studies.
- Evaluated compounds for their ability to modulate surface adhesion molecule expression and induce monocyte cytokine production.
- Assessed the impact of these modulations on T cell proliferation.
Main Results:
- The model successfully allowed for the assessment of immunomodulator activity on key components of the second signal.
- Compounds' effects on adhesion molecule expression and cytokine synthesis were correlated with their impact on T cell proliferation.
Conclusions:
- The developed accessory cell depletion and reconstitution model is effective for in vitro evaluation of immunomodulators.
- This model provides a framework for understanding how compounds influence T cell activation via the second signal, aiding in the development of novel immunotherapies.